PyInvesting

Market research

PEN Penumbra Inc

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
13B
P/E ratio
80.09
Analyst target
361.8333
Dividend yield
Not available
Beta
0.7

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Penumbra, Inc is currently in a long term uptrend where the price is trading 9.2% above its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.5.

Penumbra, Inc's total revenue rose by 14.9% to $167M since the same quarter in the previous year.

Its net income has dropped by 62.3% to $4M since the same quarter in the previous year.

Finally, its free cash flow fell by 81.4% to $-6M since the same quarter in the previous year.

Based on the above factors, Penumbra, Inc gets an overall score of 3/5.